Company Overview
Gentherm Incorporated designs, develops, manufactures, and sells thermal management and pneumatic comfort technologies in the United States, China, Germany, Czech Republic, South Korea, Mexico, Slovakia, Romania, Japan, United Kingdom and internationally. It operates in two segments, Automotive and Medical. The company offers climate comfort systems, including seat heaters, blowers, and thermoelectric devices for variable temperature climate control seats and steering wheel heaters to provide thermal comfort to automobile passengers; integrated electronic components, such as electronic control units; pneumatic lumbar and massage comfort solutions comprising lumbar support, side bolster adjustment, multi-contour seats and massage systems; and other climate and comfort systems, including neck and shoulder conditioners, and climate control systems for door panels and armrests. It also provides automotive cable technology, such as ready-made individual cables and ready-to-install cable networks used to connect components to power sources; battery performance solutions consist of cell connecting devices and battery cable technologies used for various types of batteries and thermal management products; valve systems for brake and engine systems, and fuel management; and electronic and software systems include electronic control units for climate and comfort systems, and electronic control units for memory seat modules and other devices. In addition, the company offers patient temperature management systems under the Blanketrol and Astotherm brands for hyper-hypothermia therapy in intensive care, normothermia in surgical procedures, and additional warming/cooling therapies. It serves light vehicle original equipment manufacturers and tier 1, and medical industry. Gentherm Incorporated was formerly known as Amerigon Incorporated and changed its name to Gentherm Incorporated in September 2012. The company was incorporated in 1991 and is headquartered in Northville, Michigan.
Why Investors Should Care
Net profit has compounded at 125.6% per year over the last five years.
Revenue has grown at a 22.2% CAGR over the past five years.
Carries low leverage with a debt-to-equity ratio of 0.38.
Generates positive free cash flow, funding growth and shareholder returns internally.
Recent Developments
- Dec 2025 Revenue of $1.50B (+2.9% YoY).
- Trailing 12 Months Year-on-year growth — revenue +11.3%, earnings +36.0%.
- 5-Year Trend Long-term compounding — revenue CAGR 22.2%, profit CAGR 125.6%.
Growth & Price Performance
Compounded Sales Growth
| 5 Years: | 22.16% |
| 1 Year: | 11.30% |
Compounded Profit Growth
| 5 Years: | 125.63% |
| 1 Year: | 36.04% |
Stock Price Performance
| 1 Year: | +18.96% |
| 6 Months: | -7.36% |
| 3 Months: | +21.99% |
| 1 Month: | -0.53% |
Highlights auto-generated from reported financials and price data; not investment advice. Verify with official filings before acting.
- Price vs 50-DMAAbove
- Price vs 200-DMAAbove
- Golden Cross3d ago
- RSI (14)57.21 · Neutral
P/E of 49.16 is above the sector median of 22.82 — pricier than peers.
Auto-generated from price history and fundamentals; not investment advice.
Price Chart
Technical Trend
Computed from daily close history using EMA cross, slope, and RSI signals.
Note: intraday data is not stored locally. “Hourly” uses the most recent 10 daily candles as a short-term proxy.
Fundamental Growth Charts
No fundamental data available for this stock.
Interactive charts for Revenue, Net Income, EBITDA, Free Cash Flow, EPS, ROE, ROCE, Gross/Net/Operating Margin and more — switch metric and period using the dropdowns above. CAGR is computed across the displayed window (quarterly CAGR is annualised). Visual growth charts make it easy to spot multi-year compounding trends at a glance — far faster than reading raw numbers in a table.
PROS
- Compounding revenue at 22.2% over 5 years.
- Profit CAGR of 125.6% over 5 years.
- Generates positive free cash flow.
- In a confirmed uptrend (50-DMA above 200-DMA).
CONS
No notable concerns flagged.
* The pros and cons are auto-generated from financial metrics.
Valuation
Growth (CAGR)
Profitability & Returns
Balance Sheet & Liquidity
Ownership
Financial Snapshot
Peer comparison
Peer companies in the same sector (Consumer Cyclical).
| # | Name | CMP $ | P/E | Mkt Cap | Div Yld % | ROCE % | ROE % | Rev CAGR 5Y % | Profit CAGR 5Y % |
|---|---|---|---|---|---|---|---|---|---|
| 1 | THRM Gentherm Incorporated R2K | 35.89 | 49.16 | $1.10B | 0.00% | 8.34% | 3.32% | 22.16% | 125.63% |
| 2 | AMZN Amazon.com, Inc. NDXSPXAI | 247.49 | 32.82 | $2.66T | 0.00% | 16.60% | 24.29% | 11.73% | 984.47% |
| 3 | TSLA Tesla, Inc. NDXSPXAI | 396.18 | 360.16 | $1.49T | 0.00% | 4.10% | 4.90% | 52.40% | 39.39% |
| 4 | HD The Home Depot, Inc. SPX | 337.74 | 23.97 | $336.77B | 2.84% | 28.75% | 128.38% | 1.52% | -6.11% |
| 5 | BABA Alibaba Group Holding Limited AI | 112.32 | 17.28 | $269.47B | 0.93% | 4.16% | 9.22% | 5.62% | 12.49% |
| 6 | MCD McDonald's Corporation SPX | 268.94 | 22.17 | $191.08B | 2.61% | 22.47% | - | 0.92% | 7.33% |
| 7 | TJX The TJX Companies, Inc. SPX | 150.34 | 29.25 | $166.08B | 1.14% | 21.26% | 61.25% | 6.84% | 8.48% |
| 8 | BKNG Booking Holdings Inc. NDXSPX | 174.85 | 23.04 | $135.49B | 0.97% | 70.23% | -96.88% | 16.93% | 22.07% |
| 9 | SBUX Starbucks Corporation NDXSPX | 106.17 | 81.05 | $121.00B | 2.41% | 13.46% | -22.93% | 7.93% | 5.80% |
Financial Statements Quarterly Results · Profit & Loss · Balance Sheet · Cash Flows · Ratios
Quarterly Results
Figures in USD.
| Metric | Sep 2013 | Mar 2014 | Jun 2014 | Sep 2014 | Mar 2015 | Jun 2015 | Sep 2015 | Mar 2016 | Jun 2016 | Sep 2016 | Mar 2017 | Jun 2017 | Sep 2017 | Mar 2018 | Jun 2018 | Sep 2018 | Dec 2018 | Mar 2019 | Jun 2019 | Sep 2019 | Dec 2019 | Mar 2020 | Jun 2020 | Sep 2020 | Mar 2021 | Jun 2021 | Sep 2021 | Mar 2022 | Jun 2022 | Sep 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - | - | - | - | - | - | - | 235.85M | 264.59M | 266.40M | 261.50M | 256.01M | 257.92M | 243.33M | 240.06M | 230.38M | 228.61M | 136.06M | 259.54M | 288.54M | 266.00M | 243.38M | 267.66M | 260.71M | 332.96M | 363.62M | 372.32M | 366.19M | 356.01M | 375.68M | 371.51M | 353.85M | 375.09M | 386.87M | 393.71M |
| Gross Profit | 45.92M | 57.02M | 60.76M | 61.59M | 66.57M | 65.70M | 74.93M | 68.24M | 71.50M | 76.69M | 85.16M | 78.32M | 70.19M | 81.24M | 77.09M | 75.70M | 70.82M | 75.31M | 72.71M | 74.69M | 65.62M | 66.07M | 26.73M | 82.61M | 87.67M | 79.21M | 69.39M | 64.11M | 59.38M | 80.35M | 81.13M | 87.99M | 86.21M | 88.75M | 96.70M | 94.87M | 86.47M | 89.76M | 95.15M | 97.23M |
| Operating Income | 14.55M | 25.04M | 24.51M | 24.13M | 27.08M | 26.67M | 37.45M | 29.89M | 22.35M | 27.41M | 34.85M | 25.14M | 16.13M | 20.65M | 15.59M | 15.71M | - | 21.84M | 20.06M | 20.33M | - | 18.70M | -9.90M | 38.51M | 40.75M | 31.67M | 20.70M | 14.19M | 7.74M | 22.82M | 17.67M | 4.32M | 23.74M | 18.05M | 32.99M | 32.34M | 17.06M | 24.01M | 23.86M | 11.29M |
| Net Income | 8.70M | 16.58M | 16.42M | 17.29M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Diluted EPS | 0.24 | 0.47 | 0.46 | 0.48 | 0.55 | 0.53 | 0.76 | 0.33 | 0.50 | 0.55 | 0.69 | 0.23 | 0.18 | 0.35 | 0.45 | -0.01 | 0.36 | 0.25 | 0.08 | 0.48 | 0.32 | 0.36 | -0.32 | 0.73 | 0.99 | 0.74 | 0.47 | 0.35 | 0.21 | 0.29 | 0.24 | -0.05 | 0.48 | 0.47 | 0.60 | 0.51 | 0.00 | 0.02 | 0.49 | 0.14 |
| R&D Expense | - | - | - | - | 14.55M | 14.98M | 14.93M | 15.70M | 19.11M | 19.75M | 19.50M | 21.41M | 19.72M | 23.30M | 21.02M | 19.06M | - | 18.90M | 19.25M | 18.84M | - | 17.76M | 15.34M | 18.07M | 17.60M | 18.23M | 20.59M | 20.43M | 19.32M | 22.67M | 25.14M | 24.70M | 23.15M | 22.75M | 21.86M | 23.01M | 24.22M | 22.56M | 24.43M | 23.95M |
Profit & Loss (Annual)
Figures in USD.
| Metric | Dec 2009 | Dec 2010 | Dec 2011 | Dec 2012 | Dec 2013 | Dec 2014 | Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 60.92M | 112.40M | 369.59M | 554.98M | 662.08M | 811.30M | 856.45M | 917.60M | 993.99M | 1.05B | 971.68M | 913.10M | 1.05B | 1.20B | 1.47B | 1.46B | 1.50B |
| Gross Profit | 15.76M | 32.76M | 94.97M | 141.93M | 174.76M | 241.68M | 276.38M | 295.04M | 319.19M | 304.86M | 288.33M | 268.10M | 303.63M | 273.65M | 351.62M | 366.43M | 362.18M |
| Operating Income | 908.00K | 11.36M | 17.81M | 36.66M | 50.38M | 98.43M | 121.32M | 106.12M | 97.10M | 72.79M | 84.26M | 89.22M | 115.01M | 48.31M | 77.44M | 107.02M | 82.70M |
| Net Income | 723.00K | 9.45M | 9.66M | 17.87M | 33.82M | 70.12M | 95.39M | - | - | - | - | - | - | - | - | - | - |
| Diluted EPS | 0.03 | 0.42 | 0.06 | 0.39 | 0.94 | 1.95 | 2.62 | 2.09 | 0.96 | 1.16 | 1.47 | 1.81 | 2.79 | 0.73 | 1.22 | 2.06 | 0.59 |
| R&D Expense | 8.10M | 12.71M | 30.66M | 43.19M | 49.87M | 57.53M | 59.60M | 72.92M | 82.48M | 79.90M | 72.48M | 68.04M | 75.21M | 85.72M | 94.36M | 88.70M | 94.76M |
Balance Sheet (Annual)
Figures in USD.
| Metric | Dec 2008 | Dec 2009 | Dec 2010 | Dec 2011 | Dec 2012 | Dec 2013 | Dec 2014 | Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Assets | - | - | 79.42M | 374.88M | 439.20M | 481.92M | 554.28M | 648.34M | 843.03M | 883.40M | 803.05M | 738.83M | 1.02B | 935.34M | 1.24B | 1.23B | 1.25B | 1.40B |
| Total Equity | 45.04M | 46.11M | 57.54M | 60.59M | 161.81M | 232.09M | 294.22M | 384.29M | 460.40M | 553.87M | 479.70M | 484.10M | 586.33M | 653.81M | 672.27M | 644.72M | 616.95M | 720.32M |
| Cash & Equivalents | 25.30M | 21.68M | 26.58M | 23.84M | 58.15M | 54.88M | 85.70M | 144.48M | 177.19M | 103.17M | 39.62M | 50.44M | 268.35M | 190.61M | 153.89M | 149.67M | 134.13M | 160.83M |
| Long Term Debt | - | - | - | 61.68M | 39.73M | 60.88M | 85.47M | 92.83M | 169.43M | 141.21M | 136.48M | 78.12M | 189.93M | 36.25M | 232.65M | 222.22M | 220.06M | 189.00M |
| Total Liabilities | - | - | 21.89M | 219.99M | 201.56M | 249.83M | 260.06M | 264.05M | 382.62M | 329.53M | 323.35M | 254.74M | 436.51M | 281.54M | 567.03M | 589.65M | 630.61M | 676.11M |
| Current Liabilities | - | - | 21.20M | 111.72M | 117.21M | 153.15M | 147.59M | 145.46M | 193.62M | 171.31M | 175.40M | 156.70M | 205.98M | 213.09M | 285.62M | 324.95M | 340.29M | 404.31M |
Cash Flows (Annual)
Figures in USD.
| Metric | Dec 2009 | Dec 2010 | Dec 2011 | Dec 2012 | Dec 2013 | Dec 2014 | Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | 4.25M | 11.45M | 34.23M | 36.87M | 59.79M | - | - | 108.40M | 49.88M | 118.43M | 118.80M | 110.69M | 143.08M | 14.95M | 119.27M | 109.65M | 116.79M |
| Investing Cash Flow | -8.72M | -9.08M | -115.96M | -35.40M | -84.68M | - | - | -144.34M | -117.69M | -40.76M | 5.84M | -18.22M | -48.83M | -239.90M | -24.12M | -53.53M | -52.40M |
| Financing Cash Flow | 852.00K | 2.44M | 85.55M | 32.48M | 18.90M | - | - | 79.86M | -31.56M | -139.27M | -108.59M | 115.48M | -169.14M | 189.93M | -106.05M | -51.70M | -42.48M |
| Capital Expenditure | -744.00K | -957.00K | -10.64M | -26.79M | -35.86M | -38.89M | -55.49M | -66.32M | -50.78M | -41.54M | -23.73M | -17.22M | -38.47M | -39.70M | -37.60M | -73.31M | -55.67M |
| Free Cash Flow | 3.51M | 10.50M | 23.59M | 10.07M | 23.93M | - | - | 42.08M | -905.00K | 76.89M | 95.07M | 93.48M | 104.61M | -24.76M | 81.66M | 36.33M | 61.12M |
| Share Buybacks | - | - | - | - | - | 1.11M | - | - | 5.33M | 148.07M | 63.28M | 9.09M | 20.00M | - | 91.09M | 51.59M | 10.02M |
Ratios (Annual)
Figures in %.
| Metric | Dec 2009 | Dec 2010 | Dec 2011 | Dec 2012 | Dec 2013 | Dec 2014 | Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin % | 25.9% | 29.1% | 25.7% | 25.6% | 26.4% | 29.8% | 32.3% | 32.2% | 32.1% | 29.1% | 29.7% | 29.4% | 29.0% | 22.7% | 23.9% | 25.2% | 24.2% |
| Operating Margin % | 1.5% | 10.1% | 4.8% | 6.6% | 7.6% | 12.1% | 14.2% | 11.6% | 9.8% | 6.9% | 8.7% | 9.8% | 11.0% | 4.0% | 5.3% | 7.3% | 5.5% |
| Net Margin % | 1.2% | 8.4% | 2.6% | 3.2% | 5.1% | 8.6% | 11.1% | - | - | - | - | - | - | - | - | - | - |
| ROE % | 1.6% | 16.4% | 15.9% | 11.0% | 14.6% | 23.8% | 24.8% | - | - | - | - | - | - | - | - | - | - |
| ROCE % | - | 19.5% | 6.8% | 11.4% | 15.3% | 24.2% | 24.1% | 16.3% | 13.6% | 11.6% | 14.5% | 10.9% | 15.9% | 5.1% | 8.5% | 11.8% | 8.3% |
Shareholding Pattern
Top Institutional Holders
| # | Holder | % Held | Shares | Value |
|---|---|---|---|---|
| 1 | Blackrock Inc. | 15.32% | 4.70M | $160.47M |
| 2 | Vanguard Portfolio Management LLC | 5.88% | 1.80M | $61.63M |
| 3 | Dimensional Fund Advisors LP | 4.81% | 1.47M | $50.38M |
| 4 | Trigran Investments Inc | 4.40% | 1.35M | $46.07M |
| 5 | Vanguard Capital Management LLC | 4.18% | 1.28M | $43.77M |
| 6 | State Street Corporation | 4.05% | 1.24M | $42.48M |
| 7 | Harvey Partners, LLC | 4.02% | 1.23M | $42.14M |
| 8 | Global Alpha Capital Management Ltd. | 3.89% | 1.19M | $40.71M |
| 9 | Fuller & Thaler Asset Management Inc. | 3.83% | 1.17M | $40.09M |
| 10 | Barrow, Hanley Mewhinney & Strauss, LLC | 3.16% | 968.79K | $33.10M |
Analyst View
Analyst aggregate. Targets and ratings update periodically; not investment advice.
Latest News
Recent headlines for THRM
[SCHEDULE 13G] Gentherm Inc Passive Investment Disclosure (>5%) - Stock Titan
<a href="https://news.google.com/rss/articles/CBMiuwFBVV95cUxNQ05CYmVzdkNyVXk1MDVyMVNhODQ0Sk4xM0tEa3RrWGVRdGZjX2Z2WFNFZkFGRm80RmtoNlRnN3hjZ2p6WU5KS0FWMEJfVFAzdFdpV2JPcVFzVXBuSWdiNHBUdkhkWmJ5dXpvZGJTUjEtc2phZUU4d0JieE9WTlphZEhjTWF5WE5fckRNbX…
Are Investors Undervaluing Gentherm (THRM) Right Now? - Yahoo Finance
<a href="https://news.google.com/rss/articles/CBMiqAFBVV95cUxQNFhoS0h6V1RtcWFNYkdRR0NreEJ4TnhGazhBekJYbFRmZkZsVG9ZemZxczQ5ZnhvWUtqZ1N2MTB6a0tHNWRTZkMyZWJZYWt5VTFLQjRQdGJ2QmNGSms4TnFySFdEOWlwSGNEQktidWZmb2t5Y2Jzb1Mzazh0dGtabklDQkQyMmgyeExEel…
Gentherm (NASDAQ:THRM) Stock Crosses Above Two Hundred Day Moving Average - Here's Why - MarketBeat
<a href="https://news.google.com/rss/articles/CBMizwFBVV95cUxNWUE2Q2d2VlROalBxMGdpOFBmU2FKX0pDdE5VRlM5SVU2a2NsWHJEV2ItN0NWNHdJWWdPMnlUVWpmU3Y2Y1FkS2xXRmxhWjN2SDBpQ3lOanVMaHFKaDNROHZSaDYzNW9PUkNQWnBnM1h2N1NfMUdVN2VlTHRqbmlsOVhOREhhN0psU2hhOC…
Can Gentherm’s (THRM) New Credit Facility Quietly Redefine Its Balance Sheet Playbook? - simplywall.st
<a href="https://news.google.com/rss/articles/CBMiyAFBVV95cUxNVWxYSmh6bG9XWU1qNVdxaGpIdXA1YjZqYzVyUG5uSi12Z01KdWl5WTFBWmpIdzNnX09CQTVQY0pNUUlPWUZKVmxkanlRdlhWenhQNkVNcGtTeG1nMWtkci02bGFFRzdxVjhEbGJpLWZmR2dEd3Y4MmRpR0pVVGVjazUxVWFaNDlFTDdhNF…
(THRM) Movement Within Algorithmic Entry Frameworks - Stock Traders Daily
<a href="https://news.google.com/rss/articles/CBMixwFBVV95cUxOZUgxeDNMR2U0WUJ5T3IyMFpqUnp1R0V4VVQ5WXdCakJ0U18yOG82OHN1cmk5c3BReG1wSlVyNGFFU3o1T18yUXBHT08yZHQwN1FRWVJ3Rmtoc29rRGJQVkl1ZWc5MEdmVC0yZkFST3gyUWJzUFpwV0I3Ul8wTVk3OXI2SE54NmZDMFUyaG…
THRM Forecast — Price Target — Prediction for 2027 - TradingView
<a href="https://news.google.com/rss/articles/CBMiekFVX3lxTE9takY5RV9OMVl3RWFMaVFiNXIyNmVVampFbFhIYl9UZW5YRTl1MVZPMDVNZ0JQSmJtWDU1TVVfTWJKdWpEYzBtbVIyN0huMFFURUZhNGtWSVZhVFh1Tnpqa2h0emJ2UWliSG1jSVM0a0lXRS03QnVVek5R?oc=5" target="_blank">THR…
THRM — Frequently Asked Questions
What is the current share price of Gentherm Incorporated (THRM)?
As of 2026-07-14 21:23 PDT, Gentherm Incorporated (THRM) trades at $35.89 on NasdaqGS. Its 52-week range is $27.21 to $39.05.
What is the market capitalisation of THRM?
Gentherm Incorporated (THRM) has a market capitalisation of $1.10B on NasdaqGS.
What is the P/E ratio of THRM?
THRM trades at a trailing price-to-earnings (P/E) ratio of 49.16. The industry average P/E is 22.82. Its price-to-book (P/B) ratio is 1.56.
What is the return on equity (ROE) of THRM?
THRM has a return on equity (ROE) of 3.32%. Its return on capital employed (ROCE) is 8.34%.
Is THRM a good stock to buy?
This page provides a data-driven analysis of Gentherm Incorporated (THRM), including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.